Analysts Adjust TELA Bio Price Targets Amid Mixed 2024 Results TELA Bio reported 19% revenue growth for 2024, reaching $69.3 million, but missed analyst expectations for Q4. Following these results, several firms lowered price targets, with Piper Sandler dropping to $2.00 and others to $7.00, reflecting concerns about sales momentum and competition despite continued optimism about the company’s long-term prospects.12